Gradient Investments LLC Guardant Health, Inc. Transaction History

Gradient Investments LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	SELL	$28.82 - $77.35 $1,441 - $3,867	-50 Closed	0 $0
Q1 2022 May 26, 2022	SELL	$48.25 - $100.49 $4,825 - $10,049	-100 Reduced 66.67%	50 $3,000
Q4 2021 Jan 12, 2022	BUY	$88.71 - $120.43 $8,871 - $12,043	100 Added 200.0%	150 $15,000
Q2 2020 Jul 10, 2020	SELL	$60.49 - $97.5 $423 - $682	-7 Reduced 12.28%	50 $4,000
Q1 2020 Apr 07, 2020	BUY	$59.04 - $88.81 $413 - $621	7 Added 14.0%	57 $4,000
Q2 2019 Jul 16, 2019	BUY	$63.94 - $91.11 $3,197 - $4,555	50 New	50 $4,000

331

116M

680K

1.66M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $2.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.